Versor Investments LP Charles River Laboratories International, Inc. Transaction History

Versor Investments LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$206.39 - $268.73 $1.18 Million - $1.54 Million	5,740 New	5,740 $1.19 Million
Q4 2023 Feb 07, 2024	SELL	$164.52 - $238.84 $197,753 - $287,085	-1,202 Reduced 28.02%	3,088 $730,000
Q3 2023 Nov 06, 2023	BUY	$194.44 - $217.61 $834,147 - $933,546	4,290 New	4,290 $840,000
Q4 2022 Jan 30, 2023	BUY	$197.11 - $250.07 $641,987 - $814,477	3,257 Added 271.42%	4,457 $970,000
Q3 2022 Oct 25, 2022	SELL	$182.44 - $250.54 $1.11 Million - $1.52 Million	-6,084 Reduced 83.53%	1,200 $236,000
Q2 2022 Jul 27, 2022	BUY	$204.13 - $302.4 $1.49 Million - $2.2 Million	7,284 New	7,284 $1.56 Million

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

Stay updated on Versor Investments LP with notifications on news.